Anu Airaksinen

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [Zr-89]Zr-DFO-PEG(5)-Tz (2022)

Bioconjugate Chemistry

Lumen Dave, Vugts Danielle, Chomet Marion, Imlimthan Surachet, Sarparanta Mirkka, Vos Ricardo, Schreurs Maxime, Verlaan Mariska, Lang Pauline A, Hippeläinen Eero, Beaino Wissam, Windhorst Albert D, Airaksinen Anu J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics (2022)

Nuclear Medicine and Biology

Lambidis Elisavet, Lumén Dave, Koskipahta Elina, Imlimthan Suvachet, Lopez Brianda B., Sánchez Ana Isabel Fraguas, Sarparanta Mirkka, Cheng R. Holland, Airaksinen Anu J.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography (2022)

International Symposium on Radiopharmaceutical Sciences, Nuclear Medicine and Biology

Dillemuth Pyry, Auchynnikava Tatsiana, Ayo Abiodun, Kärnä Salli, Miner Maxwell, Liljenbäck Heidi, Lopez-Picon Francisco, Roivainen Anne, Laakkonen Pirjo, Airaksinen Anu, Li Xiang-Guo

(O2 Muu julkaisu )

Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET (2022)

Molecular Pharmaceutics

Lambidis Elisavet, Chen Chun-Chieh, Baikoghli Mo, Imlimthan Surachet, Khng You C, Sarparanta Mirkka, Cheng R Holland, Airaksinen Anu J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model (2022)

Bioconjugate Chemistry

Otaru Sofia, Paulus Andreas, Imlimthan Surachet, Kuurne Iida, Virtanen Helena, Liljenbäck Heidi, Tolvanen Tuula, Auchynnikava Tatsiana, Roivainen Anne, Helariutta Kerttuli, Sarparanta Mirkka, Airaksinen Anu J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging (2021)

Nuclear Medicine and Biology

Auchynnikava Tatsiana, Li Xiang-Guo, Liljenbäck Heidi, Roivainen Anne, Airaksinen Anu

(O2 Muu julkaisu )

Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics (2021)

European Journal of Pharmaceutics and Biopharmaceutics

Lumen Dave, Wang Shiqi, Mäkilä Ermei, Imlimthan Surachet, Sarparanta Mirkka, Correia Alexandra, Westerveld Haug Christina, Hirvonen Jouni, Santos Hélder A, Airaksinen Anu J, Filtvedt Werener, Salonen Jarno

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Radiolabeling of Theranostic Nanosystems (2021)

Das Sudeep, Imlimthan Surachet, Airaksinen Anu J., Sarparanta Mirkka

(Vertaisarvioitu artikkeli kokoomateoksessa (A3))

First-in-Human Study of 68 Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1 (2021)

Journal of Nuclear Medicine

Viitanen Riikka, Moisio Olli Antero, Lankinen Petteri, Li Xiang-Guo, Koivumäki Mikko, Suilamo Sami, Tolvanen Tuula, Taimen Kirsi, Mali Markku, Kohonen Ia, Koskivirta Ilpo, Oikonen Vesa, Virtanen Helena, Santalahti Kristiina, Autio Anu, Saraste Antti, Pirilä Laura, Nuutila Pirjo, Knuuti Juhani, Jalkanen Sirpa, Roivainen Anne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates (2021)

Molecular Pharmaceutics

Matovic Jelena, Järvinen Juulia, Sokka Iris K, Imlimthan Surachet, Raitanen Jan-Erik, Montaser Ahmed, Maaheimo Hannu, Huttunen Kristiina M, Peräniemi Sirpa, Airaksinen Anu J, Sarparanta Mirkka, Johansson Mikael P, Rautio Jarkko, Ekholm Filip S

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Areas of expertise

Publications

Sort by:

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [Zr-89]Zr-DFO-PEG(5)-Tz (2022)

Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics (2022)

Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography (2022)

Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET (2022)

Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model (2022)

Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging (2021)

Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics (2021)

Radiolabeling of Theranostic Nanosystems (2021)

First-in-Human Study of 68 Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1 (2021)

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates (2021)